Aillis launched a disease awareness website about influenza treatment.

Aillis participated as a panelist in the seminar hosted by JETRO and co-hosted by the WHO Foundation.

Aillis has completed data collection related to COVID-19.

Aillis has been awarded the Global Innovation Award by the U.S. Ambassador to Japan.

Aillis, presented at the Tokyo qualifiers as the previous year's world champion.

Aillis participated in the startup mission hosted by the Ministry of Economy, Trade and Industry in Singapore.

A database (registry) of pharyngeal images is launched in collaboration between six university hospitals and Aillis.

Our CEO, Sho Okiyama, speaks at the University of Tokyo's campus festival, contributing to the career development of doctors.

Insurance coverage for medical device testing using AI officially categorized as a technical division

Aillis, developing AI medical devices, has been selected for the 'TOKYO Strategic Innovation Promotion Project' in the Reiwa 5th fiscal year.

Aillis-affiliated AI engineer achieved 4th place worldwide in the Kaggle competition co-hosted by Google and Harvard Medical School.

Our CEO, Sho Okiyama, participated as a judge in Medtec Japan.

Aillis reaches a milestone of one million pharyngeal medical images in its database.

Aillis reaches a total of 5 billion yen in Series D funding

Aillis, developer of AI medical devices, selected to exhibit at the Osaka-Kansai Expo Healthcare Pavilion

Aillis's 'NODOCA' achieves milestone with over 50,000 patients tested using AI influenza testing

Sho Okiyama, the CEO of Aillis, a company developing AI medical devices, gave a presentation at TEDxVitosha 2024.

Our CEO, Sho Okiyama, gave a presentation at the Japan Agency for Medical Research and Development.

AI medical device "nodoca" has been introduced to medical institutions in all 47 prefectures in Japan.

Our CEO, Sho Okiyama, won the "23rd Japan Venture Awards Minister of State for Science and Technology Policy Award".